| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0020300 | Exon-Exon | chr3:172003716-172025291 | chr3:172285926-172307501 | 59 nt | 0.4068 |
| hsa_FNDC3B_0020200 | Exon-Exon | chr3:172003716-172048505 | chr3:172285926-172330715 | 764 nt | 0.4791 |
| hsa_FNDC3B_0020400 | Exon-Exon | chr3:172003716-172055191 | chr3:172285926-172337401 | 72 nt | 0.4167 |
| hsa_FNDC3B_0020000 | Exon-Exon | chr3:172003716-172070873 | chr3:172285926-172353083 | 2005 nt | 0.4943 |
| hsa_FNDC3B_0020500 | Exon-Exon | chr3:172003716-172098883 | chr3:172285926-172381093 | 59 nt | 0.4068 |
| hsa_FNDC3B_0020600 | Exon-Exon | chr3:172003738-172016577 | chr3:172285948-172298787 | 37 nt | 0.4595 |
| hsa_chr3_0367700 | Intergenic-Intergenic | chr3:172007256-172007426 | chr3:172289466-172289636 | 171 nt | 0.3977 |
| hsa_chr3_0367800 | Intergenic-Intergenic | chr3:172007454-172007650 | chr3:172289664-172289860 | 197 nt | 0.5584 |
| hsa_FNDC3B_0020700 | Intron-Intron | chr3:172010244-172010946 | chr3:172292454-172293156 | 703 nt | 0.4026 |
| hsa_FNDC3B_0021000 | Exon-Exon | chr3:172013153-172016577 | chr3:172295363-172298787 | 152 nt | 0.4737 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].